Court Denies UK Agency's Appeal In Price-Fixing Spat

Law360, New York (December 4, 2008, 12:00 AM EST) -- Several pharmaceutical companies have prevailed in a long-running battle against a U.K. government agency after an appeals court rejected the office's bid to amend an indictment accusing the firms and their executives of price-fixing.

The U.K. Court of Appeals on Wednesday declined to give the Serious Fraud Office leave to appeal a lower court decision that denied its request to amend the indictment. The ruling put an end to a six-year case in which Ranbaxy (U.K.) Ltd., Goldshield Group PLC and other drug companies were charged...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.